Product Information

GABAPENTIN 100 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0209 per EA under NDC 31722014810. Its NADAC has been published 33 times since Jan 7, 2026.

FDA first approved this application on May 10, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GABAPENTIN 100 MG CAPSULE

gabapentin
$0.0209per EA
High Outlier

Strength

100 mg/1

NDC

31722014810

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA214956

FDA Approved

5/10/2021

TE Code

AB

On Market Since

5/10/2021

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 100 MG CAPSULE has been published 33 times since Jan 7, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0209 per EA
All-time high$0.0214 (Feb 11, 2026)
All-time low$0.0208 (Jul 22, 2026)
52-week high$0.0214
52-week low$0.0208
Median price$0.0211
Average price$0.0211
Largest weekly change-1.1% (Jul 22, 2026)
Weeks tracked33
Tracking sinceJan 7, 2026

Price History

1W

+1.0%

1M

+1.0%

3M

-1.0%

6M

-1.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

-1.1%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GABAPENTIN 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 100 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.0209 per EA (NDC 31722014810), effective Aug 19, 2026.

How has the price of GABAPENTIN 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 100 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 33 weekly CMS publications since Jan 7, 2026.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 100 MG CAPSULE?

Since Jan 7, 2026, the NADAC for GABAPENTIN 100 MG CAPSULE has ranged from a low of $0.0208 (Jul 22, 2026) to a high of $0.0214 (Feb 11, 2026), with a median of $0.0211 per EA.

Are there cheaper alternatives to GABAPENTIN 100 MG CAPSULE?

8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures GABAPENTIN 100 MG CAPSULE?

GABAPENTIN 100 MG CAPSULE (NDC 31722014810) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.